Publication | Closed Access

Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules

Stz-diabetes Mouse ModelMetabolic SyndromeVascular DiseaseAtherosclerosisMedicineDiabetesEndothelial DysfunctionAdhesion MoleculesVascular BiologyMicrovascular DysfunctionPharmacologyCell BiologyCell SignalingOxidative StressPlaque FormationExtracellular Matrix